Asimilobine is an inhibitor of dopamine biosynthesis, and a serotonergic receptor antagonist.[2][3]

References

  1. ^ "KNApSAcK Metabolite Information - C00025231". www.knapsackfamily.com.
  2. ^ Shoji, N; Umeyama, A; Saito, N; Iuchi, A; Takemoto, T; Kajiwara, A; Ohizumi, Y (1987). "Asimilobine and lirinidine, serotonergic receptor antagonists, from Nelumbo nucifera". Journal of Natural Products. 50 (4): 773–4. doi:10.1021/np50052a044. PMID 3430176.
  3. ^ Jin, CM; Lee, JJ; Kim, YK; Ryu, SY; Lim, SC; Hwang, BY; Lee, CK; Lee, MK (2008). "Effects of asimilobine on dopamine biosynthesis and l-DOPA-induced cytotoxicity in PC12 cells". Journal of Asian Natural Products Research. 10 (7–8): 747–55. doi:10.1080/10286020802030892. PMID 18696327. S2CID 47473525.


Allikas: http://en.wikipedia.org/wiki/Asimilobine
No tags for this post.